We should prepare ourselves for a society where amateurs can create garage bioweapons.

Are human cyborgs the future? You won’t believe how close we are to merging humans with machines! This video uncovers groundbreaking advancements in cyborg technology, from bionic limbs and brain-computer interfaces to biological robots like anthrobots and exoskeletons. Discover how these innovations are reshaping healthcare, military, and even space exploration.
Learn about real-world examples, like Neil Harbisson, the colorblind cyborg artist, and the latest developments in brain-on-a-chip technology, combining human cells with artificial intelligence. Explore how cyborg soldiers could revolutionize the battlefield and how genetic engineering might complement robotic enhancements.
The future of human augmentation is here. Could we be on the verge of transforming humanity itself? Dive in to find out how science fiction is quickly becoming reality.
How do human cyborgs work? What are the latest AI breakthroughs in cyborg technology? How are cyborgs being used today? Could humans evolve into hybrid beings? This video answers all your questions. Don’t miss it!
#ai.
#cyborg.
#ainews.
====================================
Quantum computing just got a significant boost thanks to researchers at the University of Osaka, who developed a much more efficient way to create “magic states”—a key component for fault-tolerant quantum computers. By pioneering a low-level, or “level-zero,” distillation method, they dramatically reduced the number of qubits and computational resources needed, overcoming one of the biggest obstacles: quantum noise. This innovation could accelerate the arrival of powerful quantum machines capable of revolutionizing industries from finance to biotech.
Cells depend on the precise reading of DNA sequences to function correctly. This process, known as gene expression, determines which genetic instructions are activated. When this fails, the wrong parts of the genome can be activated, leading to cancers and neurodevelopmental disorders.
Scientists at the University of Geneva (UNIGE) have identified two proteins that play a key role in regulating this essential mechanism, paving the way for promising new treatments that could be more effective and less toxic than those currently available. Their findings are published in Nature Communications.
Human DNA contains over 20,000 genes and would stretch nearly two meters if fully uncoiled. To fit this enormous amount of information into a tiny space within a cell—just 10 to 100 micrometers in diameter—it must be tightly compacted. This is the job of chromatin, a complex of proteins that packages and condenses DNA within the cell nucleus.
Engineering biology applies synthetic biology to address global environmental challenges like bioremediation, biosequestration, pollutant monitoring, and resource recovery. This perspective outlines innovations in engineering biology, its integration with other technologies (e.g., nanotechnology, IoT, AI), and commercial ventures leveraging these advancements. We also discuss commercialisation and scaling challenges, biosafety and biosecurity considerations including biocontainment strategies, social and political dimensions, and governance issues that must be addressed for successful real-world implementation. Finally, we highlight future perspectives and propose strategies to overcome existing hurdles, aiming to accelerate the adoption of engineering biology for environmental solutions.
The scale of global environmental challenges requires a multi-pronged approach, which utilises all the technologies at our disposal. Here, authors provide their perspective on the potential of engineering biology for environmental biotechnology, summarizing their thoughts on the key challenges and future possibilities for the field.
The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.
While PCR (polymerase chain reaction) tests are the gold standard for detecting viral infections, they remain a challenge for screening large numbers of people in places vulnerable to outbreaks—such as health care centers and nursing homes—due to high costs and the fact that different tests are required for each virus.
A new Yale study, however, finds that an alternate strategy—using a nasal swab to screen for an antiviral protein produced by the body as a defense against infection—can be an effective method for ruling out respiratory infections, limiting PCR testing only to those most likely to be infected, at a fraction of the cost.
Researchers at the University of California, Irvine have successfully performed preclinical laboratory testing of a replacement heart valve intended for toddlers and young children with congenital cardiac defects, a key step toward obtaining approval for human use. The results of their study were published recently in the Journal of the American Heart Association.
The management of patients with congenital heart disease who require surgical pulmonary valve replacement typically occurs between the ages of 2 and 10. To be eligible for a minimally invasive transcatheter pulmonary valve procedure, patients currently must weigh at least 45 pounds. For children to receive minimally invasive treatment, they must be large enough so that their veins can accommodate the size of a crimped replacement valve.
The Iris Valve, designed and developed by the UC Irvine team, can be implanted in children weighing as little as 17 to 22 pounds and gradually expanded to an adult diameter as they grow.